Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus

Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity. Objective: In this study, ou...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehmet Enes Güner, Perihan Ozturk, Mine müjde Kuş
Format: Article
Language:English
Published: Mattioli1885 2025-01-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/4969
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540726078996480
author Mehmet Enes Güner
Perihan Ozturk
Mine müjde Kuş
author_facet Mehmet Enes Güner
Perihan Ozturk
Mine müjde Kuş
author_sort Mehmet Enes Güner
collection DOAJ
description Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity. Objective: In this study, our objective was to investigate changes in the inflammatory markers NLR, PLR, MPV, LMR, CRP and ESR, which are inflammatory markers, before treatment and during follow-up, and the correlation of disease severity with these markers in patients with pemphigus receiving IVIG and/or systemic immunosuppressant agents. Method: 76 pemphigus patients who received systemic treatment, and used these treatments for at least 6 months were included. Changes in NLR, PLR, LMR, MPV, CRP and sedimentation values were examined in patients who received systemic treatment for at least 6 months, before the start of treatment and 3 and 6 months after the start of treatment. Results: Significant changes in inflammatory markers and correlation values were found in all patients. Conclusions: We think that neutrophil, platelet, NLR and PLR values can be used to monitor the response to treatment in pemphigus, since they show a significant decrease with treatment and are significantly positively correlated with PDAI, which indicates the severity of the disease. LMR values were indicators of a poor prognosis. We found that the duration of remission was longer in the group receiving IVIg. Although there was no difference between the treatments in terms of disease recovery, only IVIg prolonged the duration of remission.
format Article
id doaj-art-8e3461fb83c14ed2a7f5e69da9575553
institution Kabale University
issn 2160-9381
language English
publishDate 2025-01-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-8e3461fb83c14ed2a7f5e69da95755532025-02-04T15:41:25ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4969Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With PemphigusMehmet Enes Güner0https://orcid.org/0000-0001-5424-4674Perihan Ozturk1https://orcid.org/0000-0002-9303-6808Mine müjde Kuş2https://orcid.org/0000-0003-3928-7005Kahramanmaras Sutcu Imam University, Kahramanmaras, TurkeyKahramanmaras Sutcu Imam University, Kahramanmaras, TurkeyKahramanmaras Sutcu Imam University, Kahramanmaras, Turkey Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity. Objective: In this study, our objective was to investigate changes in the inflammatory markers NLR, PLR, MPV, LMR, CRP and ESR, which are inflammatory markers, before treatment and during follow-up, and the correlation of disease severity with these markers in patients with pemphigus receiving IVIG and/or systemic immunosuppressant agents. Method: 76 pemphigus patients who received systemic treatment, and used these treatments for at least 6 months were included. Changes in NLR, PLR, LMR, MPV, CRP and sedimentation values were examined in patients who received systemic treatment for at least 6 months, before the start of treatment and 3 and 6 months after the start of treatment. Results: Significant changes in inflammatory markers and correlation values were found in all patients. Conclusions: We think that neutrophil, platelet, NLR and PLR values can be used to monitor the response to treatment in pemphigus, since they show a significant decrease with treatment and are significantly positively correlated with PDAI, which indicates the severity of the disease. LMR values were indicators of a poor prognosis. We found that the duration of remission was longer in the group receiving IVIg. Although there was no difference between the treatments in terms of disease recovery, only IVIg prolonged the duration of remission. https://dpcj.org/index.php/dpc/article/view/4969IVIGremissionpemphigusinflammatory markers
spellingShingle Mehmet Enes Güner
Perihan Ozturk
Mine müjde Kuş
Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
Dermatology Practical & Conceptual
IVIG
remission
pemphigus
inflammatory markers
title Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
title_full Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
title_fullStr Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
title_full_unstemmed Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
title_short Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
title_sort evaluation of the effects of systemic therapy on inflammatory markers and disease severity in patients with pemphigus
topic IVIG
remission
pemphigus
inflammatory markers
url https://dpcj.org/index.php/dpc/article/view/4969
work_keys_str_mv AT mehmetenesguner evaluationoftheeffectsofsystemictherapyoninflammatorymarkersanddiseaseseverityinpatientswithpemphigus
AT perihanozturk evaluationoftheeffectsofsystemictherapyoninflammatorymarkersanddiseaseseverityinpatientswithpemphigus
AT minemujdekus evaluationoftheeffectsofsystemictherapyoninflammatorymarkersanddiseaseseverityinpatientswithpemphigus